Virtus LifeSci Biotech Clinical Trials ETF
17 hedge funds and large institutions have $7.9M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.38M | |
| 2 | +$579K | |
| 3 | +$389K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$277K |
| 5 |
LSA
Liberty Street Advisors
New York
|
+$204K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$471K | |
| 3 | -$14.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.7K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$2.89K |